The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2002-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JC.2002-021069PMID 12466322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of physical exercise on the wedged and free hepatic venous pressure in normal men.

  2009cited by this paper
• Telomerase activity in benign and malignant adrenal tumors.

  2009cited by this paper
• On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes.

  2009cited by this paper
• Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours

  2004cited by this paper
• Adrenal incidentaloma: a new cause of the metabolic syndrome?

  2003cited by this paper
• von Hippel-Lindau disease.

  2003cited by this paper
• Multiple endocrine neoplasia type 2A: an unusual clinical presentation and association with renal dysplasia.

  2003cited by this paper
• Hyperplasia versus adenoma in endocrine tissues: are they different?

  2002cited by this paper
• Small changes in expression affect predisposition to tumorigenesis

  2002cited by this paper
• Regulation of Ras signaling by the cell cycle.

  2002cited by this paper
• Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome

  2002cited by this paper
• Adrenal Involvement in Multiple Endocrine Neoplasia Type 1

  2002cited by this paper
• Comparative genomic hybridization analysis of adrenocortical tumors.

  2002cited by this paper
• Survivin: a novel neuroendocrine marker for pheochromocytoma.

  2002cited by this paper
• Multiple roles of the tumor suppressor p53

  2002cited by this paper
• Pheochromocytoma in von hippel-lindau disease: Distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2

  2002cited by this paper
• Germ-line mutations in nonsyndromic pheochromocytoma.

  2002cited by this paper
• Successful laparoscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome

  2002cited by this paper
• Adrenal incidentaloma: a new cause of the metabolic syndrome?

  2002cited by this paper
• Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma

  2002cited by this paper
• Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.

  2002cited by this paper
• RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

  2001cited by this paper
• An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

  2001cited by this paper
• Monoclonality of endocrine tumours: What does it mean?

  2001cited by this paper
• Discerning malignancy in adrenocortical tumors: are molecular markers useful?

  2001cited by this paper
• Genetics of the Development and Function of the Adrenal Cortex

  2001cited by this paper
• Molecular and structural analysis of two novel StAR mutations in patients with lipoid congenital adrenal hyperplasia.

  2001cited by this paper
• Reassignment of the EPB4·1 gene to 1p36 and assessment of its involvement in neuroblastomas

  2001cited by this paper
• Familial hyperaldosteronism.

  2001cited by this paper
• The GDNF/RET signaling pathway and human diseases.

  2001cited by this paper
• Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.

  2001cited by this paper
• Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

  2001cited by this paper
• Multiple endocrine neoplasia type 1: new clinical and basic findings.

  2001cited by this paper
• Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.

  2001cited by this paper
• An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors.

  2001cited by this paper
• Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms

  2001cited by this paper
• Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome.

  2001cited by this paper
• Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma

  2001cited by this paper
• Guidelines for diagnosis and therapy of MEN type 1 and type 2.

  2001cited by this paper
• The von Hippel-Lindau tumor suppressor gene.

  2001cited by this paper
• CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

  2001cited by this paper
• Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors.

  2001cited by this paper
• Do somatic RET mutations represent a phenomenon of tumor progression

  2001cited by this paper
• Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.

  2000cited by this paper
• Primäre pigmentierte noduläre adrenokortikale Dysplasie (PPNAD) im Rahmen des Carney-Komplexes als Ursache eines Cushing-Syndroms

  2000cited by this paper
• Divergent differentiation in neuroendocrine tumors of the adrenal gland.

  2000cited by this paper
• Beckwith-Wiedemann syndrome and virilizing cortical adrenal tumor in a child.

  2000cited by this paper
• Presence of a Gs alpha mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing's syndrome.

  2000cited by this paper
• The role of the insulin‐like growth factor system in adrenocortical tumourigenesis

  2000cited by this paper
• Limitations of size as a criterion in the evaluation of adrenal tumors.

  2000cited by this paper
• Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

  2000cited by this paper
• A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)

  2000cited by this paper
• Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas.

  2000cited by this paper
• Complete sequencing and mRNA expression analysis of the MEN-I gene in adrenal myelolipoma.

  2000cited by this paper
• Presence of a Gsα mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing's syndrome

  2000cited by this paper
• Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex.

  2000cited by this paper
• Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high‐level amplifications

  2000cited by this paper
• Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex

  2000cited by this paper
• Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

  2000cited by this paper
• [Primary pigmented nodular adrenocortical dysplasia (PPNAD) within the scope of Carney complex as the etiology of Cushing syndrome].

  2000cited by this paper
• Clonal patterns in phaeochromocytomas and MEN‐2A adrenal medullary hyperplasias: histological and kinetic correlates

  2000cited by this paper
• Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.

  2000cited by this paper
• Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.

  2000cited by this paper
• Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.

  2000cited by this paper
• Mutation analysis of Gsalpha, adrenocorticotropin receptor and p53 genes in Japanese patients with adrenocortical neoplasms: including a case of Gsalpha mutation.

  2000cited by this paper
• High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.

  2000cited by this paper
• Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex.

  2000cited by this paper
• C‐cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B

  2000cited by this paper
• Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genomic hybridization

  1999cited by this paper
• No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours

  1999cited by this paper
• Clinical implications of genetic defects in G proteins: oncogenic mutations in G alpha s as the molecular basis for the McCune-Albright syndrome.

  1999cited by this paper
• von Recklinghausen's disease and pheochromocytomas.

  1999cited by this paper
• RET proto-oncogene in the development of human cancer.

  1999cited by this paper
• MEN1 Gene mutation analysis of sporadic adrenocortical lesions

  1999cited by this paper
• Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.

  1999cited by this paper
• Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis.

  1999cited by this paper
• [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].

  1999cited by this paper
• MEN I gene mutations in sporadic adrenal adenomas

  1999cited by this paper
• MEN1 gene analysis in sporadic adrenocortical neoplasms.

  1999cited by this paper
• Prognostic value of p53, bcl‐2, and c‐erbB‐2 protein expression in phaeochromocytomas

  1999cited by this paper
• Inactivation of the p16 tumor suppressor gene in adrenocortical tumors.

  1999cited by this paper
• Paradoxical Response to Dexamethasone in the Diagnosis of Primary Pigmented Nodular Adrenocortical Disease

  1999cited by this paper
• Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome.

  1999cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society MEN1 Gene Analysis in Sporadic Adrenocortical Neoplasms*

  1998cited by this paper
• Alterations of RET, Oncogene in Human Adrenal Tumors

  1998cited by this paper
• P53 protein and its messenger ribonucleic acid in human adrenal tumors

  1998cited by this paper
• Mutations of K-ras oncogene in human adrenal tumours in Taiwan.

  1998cited by this paper
• Germline mutations in the vhl gene in patients presenting with phaeochromocytomas

  1998cited by this paper
• Telomerase activity as an indicator of potentially malignant adrenal tumors

  1998cited by this paper
• Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features

  1998cited by this paper
• Identification of a novel genetic locus for familial cardiac myxomas and Carney complex.

  1998cited by this paper
• Prognostic value of RET proto‐oncogene point mutations in malignant and benign, sporadic phaeochromocytomas

  1998cited by this paper
• Elevated levels of telomerase activity in malignant pheochromocytoma

  1998cited by this paper
• Telomerase activity in the differentiation of benign and malignant adrenal tumors.

  1998cited by this paper
• Prognostic markers in pheochromocytoma.

  1998cited by this paper
• Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals.

  1998cited by this paper
• The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas.

  1998cited by this paper
• Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma.

  1997cited by this paper
• Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors.

  1997cited by this paper
• Expression and prognostic value of c‐erbB‐2 oncogene product in human phaeochromocytomas

  1997cited by this paper

• Clinical Outcomes of Patients with Adrenal Incidentaloma - Hypertension being a Continuous Risk Factor for the Presence of Comorbidity: A Single Center's Eight-year Experience.

  2025cites this paper
• Evaluation of the carcinogenicity of carbon tetrachloride

  2023cites this paper
• Case Report: Adrenocortical carcinoma in an adult male with hypokalemic hypertensive: Report of a rare case in Nepal

  2022cites this paper
• Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience

  2022cites this paper
• Adrenal Mass in a 70-Year-Old Woman

  2022cites this paper
• Clinical, Laboratory, and Radiological Diagnosis of Hypercortisolism

  2022cites this paper
• Pediatric adrenocortical carcinoma

  2022cites this paper
• Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

  2021cites this paper
• Prophylactic Adrenalectomy

  2021cites this paper
• A case of adrenocortical adenoma harboring venous thrombus mimicking adrenal malignancy.

  2021cites this paper
• Two Subsequent Metachroneus Solid Tumors: Oncocytic Variant Adrenocortical Carcinoma and Rhabdomyosarcoma of Childhood: Case Report and Literature Review

  2020influential citation
• A novel heat shock protein 90 inhibitor potently targets adrenocortical carcinoma tumor suppression.

  2020cites this paper
• Adrenal Incidentaloma

  2020cites this paper
• Infantile virilisation caused by an androstenedione-producing adrenal adenoma

  2019cites this paper
• [Comprehensive treatment of adrenal cortical carcinoma].

  2019cites this paper
• Pediatric Mixed Functioning Adrenocortical Carcinoma: A Case Report and Review of Literature

  2019cites this paper
• Cushing’s Syndrome and Glucocorticoid Excess

  2018cites this paper
• Oncocytoma of the adrenal gland in Birt-Hogg-Dube syndrome

  2018cites this paper
• PIGMENT (BLACK) ADRENAL ADENOMA: DIFFICULTIES OF MORFOLOGICAL DIAGNOSIS

  2018cites this paper
• The Evaluation and Management of Adrenal Masses and Adrenocortical Tumors (Act)

  2018cites this paper
• Parathyroid Hormone Resistance and Bilateral Macronodular Adrenocortical Disease: Does Partial Loss of Methylation at the GNAS Exon 1 Differentially Methylated Region (DMR) Play a Role?

  2017cites this paper
• 58-Year-Old Man With Hypertension and Diffuse Swelling.

  2017cites this paper
• Surgical approaches in hereditary endocrine tumors

  2017cites this paper
• A Clinical Perspective of Adrenocortical Carcinoma

  2016cites this paper
• Nebennierenrindenkarzinome: eine Übersicht

  2016cites this paper
• Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.

  2016cites this paper
• Carcinomes corticosurrénaliens: aperçu

  2016cites this paper
• Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype

  2016cites this paper
• Tumours of the Adrenal Gland

  2016cites this paper
• Chapter 110 – Pheochromocytoma

  2016cites this paper
• Chapter 103 – Adrenal Causes of Cushing’s Syndrome

  2016cites this paper
• Endocrine Hypertension and Chronic Kidney Disease

  2015cites this paper
• Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.

  2015cites this paper
• Chronic kidney disease and hypertension

  2015cites this paper
• Adrenal Incidentaloma and Subclinical Cushing’s Syndrome: A Longitudinal Follow-Up Study by Endoscopic Ultrasound

  2015cites this paper
• Abnormal Responsiveness to Dexamethasone-Suppressed CRH Test in Patients With Bilateral Adrenal Incidentalomas.

  2015cites this paper
• Adrenocortical Carcinoma: A Clinician's Perspective.

  2015cites this paper
• Aspects of MEN 1 Tumorigenesis in Endocrine Pancreas and Adrenal Glands

  2015cites this paper
• Aspects of MEN1 Tumorigenesis in Endocrine Pancreas and Adrenal Glands

  2015cites this paper
• Adrenocortical carcinoma: the management of metastatic disease.

  2014cites this paper
• A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers

  2014cites this paper
• Genetics and the Clinical Approach to Paragangliomas

  2014cites this paper
• Ultrasound Imaging in the Diagnosis of Benign and Suspicious Adrenal Lesions

  2014cites this paper
• Neurofibromatosis type 1 with adrenal pheochromocytoma and renal artery stenosis: an uncommon entity of arterial hypertension

  2014cites this paper
• Malignant Pheochromocytoma in a 16-Year-Old Patient with Neurofibromatosis Type 1

  2014cites this paper
• Analysis of IGF and IGFBP as Prognostic Serum Biomarkers for Adrenocortical Carcinoma

  2014cites this paper
• Analysis of circulating microRNAs in adrenocortical tumors

  2014cites this paper
• Laparoscopic adrenalectomy for cancer.

  2013cites this paper
• A rare coexistence of non-functional adrenocortical carcinoma and multicentric papillary thyroid microcarcinoma: a case report

  2013cites this paper
• In silico analysis of pathways affected by differentially expressed microRNA in adrenocortical tumors

  2013cites this paper
• Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics

  2013cites this paper
• A differential diagnosis of inherited endocrine tumors and their tumor counterparts

  2013cites this paper
• Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.

  2013cites this paper
• Bilateral Adrenal Myelolipomas in a Woman With Chronic Anticoagulation, Postmenopausal Uterine Bleeding, Primary Hyperparathyroidism and Hyperthyroidism

  2013cites this paper
• Funktionserhaltende Adrenalektomie bei Nebennierentumoren

  2012cites this paper
• Acquisition Order of Ras and p53 Gene Alterations Defines Distinct Adrenocortical Tumor Phenotypes

  2012cites this paper
• Neuroendocrine TumorsPractice Guidelines in Oncology

  2012cites this paper
• Adrenal Carcinoma - A Case Report

  2012cites this paper
• 14 Adrenal Cortex Tumors and Hyperplasias

  2012cites this paper
• Endocrine hypertension: What is new?

  2012cites this paper
• Ganglioneuroma: An Overview

  2012cites this paper
• Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1

  2012cites this paper
• Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas

  2012cites this paper
• The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis.

  2012cites this paper
• Neuroendocrine tumors.

  2012cites this paper
• Prevalence and cardiometabolic associations of the glucocorticoid receptor gene polymorphisms N363S and BclI in obese and non-obese black and white Mississippians

  2012cites this paper
• Adrenocortical carcinoma: Report of two cases

  2011cites this paper
• High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management

  2011cites this paper
• Differential expression of somatostatin receptor subtype-related genes and proteins in non-functioning and functioning adrenal cortex adenomas.

  2011cites this paper
• Adrenal Cortex Tumors and Hyperplasias

  2011cites this paper
• A Case Report of Bilateral Adrenocortical Carcinoma Complicated by Adrenal Insufficiency

  2011cites this paper
• The Pathogenesis of Pheochromocytomas: Of Mice and Men

  2011cites this paper
• [Pathogenesis of adrenocortical cancer].

  2010cites this paper
• Mouse models of endocrine tumours.

  2010cites this paper
• Mouse Models of Endocrine Tumors

  2010cites this paper
• ACTH-Independent Cushing’s Syndrome: Adrenocortical Tumors

  2010cites this paper
• Current issues in the diagnosis and management of adrenocortical carcinomas

  2010cites this paper
• Best Practice & Research Clinical Endocrinology & Metabolism

  2010cites this paper
• 9 – Adrenal Gland

  2010cites this paper
• Feocromocitoma: Diagnóstico y tratamiento

  2010cites this paper
• Adrenocortical development and cancer: focus on SF-1.

  2010cites this paper
• The Weiss system for evaluating adrenocortical neoplasms: 25 years later.

  2009cites this paper
• Adrenal tumors in MEN1 syndrome and the role of menin in adrenal tumorigenesis.

  2009cites this paper
• Genetic Mechanisms of Tumourigenesis in von Hippel-Lindau-Associated Tumours with the Emphasis on Capillary Hemangioblastoma

  2009cites this paper
• Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.

  2009cites this paper
• Osteopontin stimulates invasion of NCI‐h295 cells but is not associated with survival in adrenocortical carcinoma

  2009cites this paper
• Transcriptional profiling enables molecular classification of adrenocortical tumours.

  2009cites this paper
• Management of adrenocortical carcinoma.

  2009cites this paper
• Malignant extra-adrenal pheochromocytoma caused by an SDHB intronic variation leading to a 54-bp deletion in exon 4

  2009cites this paper
• [Recent data in adrenocortical tumorigenesis].

  2009cites this paper
• A matter of dosage: SF-1 in adrenocortical development and cancer.

  2009cites this paper
• Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma.

  2009cites this paper
• NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

  2009cites this paper
• Candidate Genes Associated With Malignant Pheochromocytomas by Genome-Wide Expression Profiling

  2009cites this paper
• Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors

  2009cites this paper
• Review Paper: Origin and Molecular Pathology of Adrenocortical Neoplasms

  2009cites this paper
• The Adrenals in Oncology

  2009cites this paper
• Conditional Pten knock‐out mice: a model for metastatic phaeochromocytoma

  2009cites this paper
• Overview of Endocrine Hypertension

  2009cites this paper
• Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation

  2008cites this paper